Titan Pharmaceuticals, Inc. TTNP · Stock Open Titan Pharmaceuticals, Inc. in new tab
Titan Pharmaceuticals, Inc. Analysis (TTNP)
Is Titan Pharmaceuticals, Inc. a good investment? Titan Pharmaceuticals, Inc. (TTNP) is currently trading at 2.34 USD.
Earnings Schedule: Titan Pharmaceuticals, Inc. is expected to release its next earnings report on Jan. 1, 2026. The market consensus estimate for Forward EPS is -0.91.
Investor FAQ
Does Titan Pharmaceuticals, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Titan Pharmaceuticals, Inc.?
Titan Pharmaceuticals, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Jan. 1, 2026. The company currently has a trailing EPS of -2.92.
Company Profile
As of October 1, 2025, Titan Pharmaceuticals, Inc. was acquired by KE Sdn Bhd, in a reverse merger transaction. Titan Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the development of therapeutics for the treatment of chronic diseases. Titan Pharmaceuticals, Inc. was founded in 1991 and is based in New York, New York.
| Split Date | Split Ratio to 1 |
|---|---|
| Sept. 29, 2015 | 0.18 |
| Jan. 25, 2019 | 0.17 |
| Dec. 1, 2020 | 0.03 |
| Jan. 9, 2024 | 1:20 |
Community Discussion